抽象的な

Pharma Europe 2019: Biomanufacturing of Biopharmaceuticals - Ganapathy Sivakumar -University of Houston

Ganapathy Sivakumar

Biomanufacturing has become an emerging industry of strategic importance worldwide and is one among the key technology areas identified by the US Advanced Manufacturing Partnership (AMP) as an appropriate target for public-private investment to support advances in manufacturing and U.S. competitiveness. the event of advanced biomanufacturing technologies consortium will foster and support the fast growing biomanufacturing industry and establish sustained leadership of the US within the area. This session organized by the Biomanufacturing Science and Technology Consortium (BSTC) team will feature experts from government, academia and industry and seek to: 1) discuss the challenges and drivers of biomanufacturing in upstream, downstream and drug product processing, 2) identify the main scientific/technological, operational and regulatory barriers within the biopharmaceutical industry, and 3) define a pre-collaborative work space for companies, academia and regulatory authorities. Biomanufacturing produces a good range of biobased products for the emerging global bioeconomy. Biomanufacturing begins with bioprospecting ? the invention and commercialization of latest products supported biologic resources.